Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Should not yet change RAS inhibitor strategies; leaves open therapeutic relevance of tissue and intracellular systems.
Richard N. Ré (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: